Carl Zeiss Meditec AG
Company profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX and SDax of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 4,224 employees (as of 30 September 2019) worldwide, the Group generated revenue of EUR 1,902.8m in fiscal year 2021/22 (as of 30 September).
The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.
The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.
IR contact
![Sebastian FrericksDirector Investor Relations](https://irpages2.eqs.com/membersarea/companies/czmeditec/pics/sebastian_frericks.jpg)
Sebastian Frericks
Director Investor Relations
Phone: +49 (0) 36 41 / 2 20 -1 16
Fax: +49 (0) 36 41 2 20 – 1 17
E-Mail: investors.meditec@zeiss.com
![Sebastian FrericksDirector Investor Relations](https://www.eqs-news.com/app/themes/master/resources/assets/images/dummy-pic.png)
Sebastian Frericks
Director Investor Relations
Phone: +49 (0) 36 41 / 2 20 -1 16
Fax: +49 (0) 36 41 2 20 – 1 17
E-Mail: investors.meditec@zeiss.com